Clock

Clock

The re-rating this framework hunts for has already happened. General Motors fell on the 2025 tariff shock, bottomed near $42 in April 2025, and closed at an all-time high of $90.30 on 28 July 2026 — above every pre-tariff level. The feared event did not break the earnings power; management has raised 2026 guidance twice and retired 35% of the share count since 2023. Consensus is already positioned "Buy." Long-dated listed options exist; implied volatility sits near 38%.

The clock has already run

The Clock tab asks what would make the market re-recognize value, and roughly when. For GM the honest answer is that the mechanism has largely fired. The stock's most recent dislocation — a tariff-driven decline from a local peak of $60.20 on 25 November 2024 to a trough of $42.48 on 8 April 2025, a fall of about 29% — reversed over the following fifteen months. GM last closed at $90.30, its highest close since the 2010 re-listing, sitting at the very top of its 52-week range ($52.11–$90.30).

Source: derived from the run's daily price history (data/prices/daily.json), quarter-end closes; latest close 28 July 2026, an all-time high.

For Ruchir's system the consequence is direct: the entry trigger it looks for — peak fear, forced selling, a stock anchored to a temporary earnings cut — is not present today. The dislocation anatomy sits in Dislocation; what remains for this tab is the mechanism that closed the gap, GM's own base rates for how long such gaps take, and the instrument facts.

What closed the gap — the mechanisms, dated

Three mechanisms drove the recovery, and each is documented in the record rather than inferred.

A feared event that failed to break earnings power. The 2025 decline tracked the imposition of U.S. auto and parts tariffs. GM addressed the parts-stacking and offset mechanics from its Q1 2025 call onward [1], and by Q3 2025 guided to offsetting roughly 35% of the gross tariff impact through go-to-market, cost, and footprint initiatives [2]. On the Q2 2026 call (21 July 2026) management reported North America EBIT-adjusted margin back to 8.6%, "solidly back within our 8%–10% margin target," up 2.5 points from a year earlier "when tariffs were first put into place" [3]. Full-year gross tariff cost is still guided at $2.5–3.5 billion, largely flat year-over-year [4]. The tariff was absorbed, not survived narrowly.

Guidance resetting against a low bar. GM raised 2026 guidance twice in the first half — the Q2 call marked the second raise of the year [5], lifting EBIT-adjusted to $14–16 billion, adjusted EPS to $12–14, and adjusted automotive free cash flow to $9.5–11.5 billion [6]. A tariff-depressed 2025 base made the upward revisions easy for the market to reward.

Buybacks shrinking the denominator. This is the most durable of the three and the one still running. Diluted share count ended Q2 2026 at 893 million, about 8% below Q2 2025 and 35% below Q2 2023, with $3.5 billion remaining under the current authorization [7]. Across the full-year figures the count has fallen from roughly 1.57 billion shares in 2016 to 973 million at fiscal 2025 — a five-year retirement CAGR of about −7.6%.

Source: share counts from data/ruchir/fit_features.json (share_count_trend), derived from company filings; Q2 2026 interim count of 893M from the Q2 FY2026 transcript [8].

The buyback flywheel is the mechanism most aligned with the framework — at a double-digit consensus FCF yield, retirements alone add materially to per-share figures — but its power was greatest at the 2025 lows, not at today's price. The executed-repurchase record and management's stated intent are examined in Self-Help.

Base rates from GM's own history

Since its 2010 re-listing GM has been a serial deep-drawdown name — a quality-plus-cyclical franchise whose price swings far more than its intrinsic value. Four episodes since 2011 fell 35% or more from a prior high; every one eventually recovered to that high, but the round trips ran roughly three to four years.

Source: derived from the run's daily price history (data/prices/daily.json); depth = (trough close − peak close) ÷ peak close, running-peak method. Recompute inputs below.

Source: derived from data/prices/daily.json. Episode peaks/troughs (close): $38.98 (Jan-2011)→$18.80 (Jul-2012); $41.53 (Dec-2013)→$26.90 (Feb-2016); $46.48 (Oct-2017)→$16.80 (Mar-2020); $65.74 (Jan-2022)→$26.65 (Nov-2023). Recovery = first close back at the prior peak.

The arithmetic a skeptic can recompute: median drawdown depth across the four is about 55%; peak-to-trough took 19–29 months; trough-to-recovery took 10–23 months; full round trips ran 1,060–1,386 days (roughly 2.9–3.8 years). The 2020 episode was the deepest (−64%) but recovered fastest (10 months from the COVID trough), because the shock was macro and V-shaped. The relevant clock for this framework — which would enter near maximum fear, not at the peak — is the trough-to-recovery leg: 10–23 months, centered near 18.

The current episode does not appear as a fifth deep drawdown on the running-peak method, because the 2024–25 tariff dip bottomed at $42.48 — below the November-2024 local peak of $60.20 but above the deeper 2023 trough — and the stock then made new highs. The deterministic capitulation gauge measured that dip at −29% with a volume spike of only about 1.6x median (capitulation_gauge in data/ruchir/fit_features.json): a real decline, but shallower than GM's historical capitulations and without the forced-selling volume signature the framework treats as peak fear. That reading is developed in Dislocation.

The 18-month test

GM's own base rates make re-recognition within 18–24 months a reasonable expectation for an entry made near a trough — trough-to-recovery has run 10–23 months in every prior deep episode, centered near eighteen. But that test is retrospective here: there is no live dislocation to time. At $90.30, an all-time high with the 52-week position at 100%, the re-rating has already occurred. The read would flip to a live 18-month clock only if a new drawdown of comparable depth opened and the driving mechanism — the tariff/pricing normalization already largely complete, or a future industry repricing — failed to fire on schedule (the falsifier-ledger conditions: FCF or EBIT beginning to slide where flat was underwritten, or three consecutive years of revenue decline).

What consensus expects, and when

The sell side is already positioned for the recovery it has, in effect, been paid to wait for. Across aggregators the consensus rating is "Buy" / "Moderate Buy" — on one 27-analyst tally, 21 of 27 rate Strong Buy or Buy — with a mean price target of about $98.65 (a second aggregator's mean is $103.10). Against the 28 July close of $90.30 that implies roughly 9–14% of upside to the average target, with a target range of $61–$132.

Source: consensus free-cash-flow means from data/ruchir/fit_features.json (consensus_forward_yield, CapIQ), scaled to absolute; yield on the 28 July 2026 market capitalization of about $87.9 billion.

Consensus does not expect a recovery to appear in future printed numbers — it already has. First-half 2026 adjusted diluted EPS of $7.27 was GM's best first half ever, more than 25% above the prior high [9], and FCF has run consistently above $10 billion since 2022 versus a $3–5 billion decade average [10]. On CapIQ's path, forward FCF rises from about $9.9 billion (2026) to $11.9 billion (2028), a forward yield climbing from roughly 11% to 14% on the current market capitalization — the sell-side already agrees the yield clears a double-digit bar. (Whether it clears Ruchir's adjusted yield bar, after stock-based compensation and acquisition spend, is a separate question taken up in Yield, where the adjustment is not computable from the current feed.)

The candidate printed quarter for the next incremental move is Q3 2026, expected around 20 October 2026 (management has confirmed no date beyond the July report). Management has already flagged 2027 as a growth year — expecting to grow revenue, margins, EBIT, and free cash flow — driven by EV-loss reduction, OnStar digital revenue, warranty gains, and a full year of the next-generation Silverado and Sierra, which begin arriving in December 2026 [11]. These are drivers of continued compounding, not of a gap-closing re-rating; the gap is closed.

The instrument facts

Long-dated listed options on GM exist. Standard equity LEAPS are listed with January 2027 and January 2028 expiries — the January 2028 series was introduced in September 2025 — so contracts with more than 18 months to expiry are available on the name. GM is a mega-cap NYSE constituent with an actively traded listed-options market across weekly, monthly, and LEAPS expiries; a precise, dated open-interest figure was not captured from a citable source, so it is stated only at that qualitative level.

On implied volatility: per third-party options-market data (AlphaQuery), GM's 30-day mean implied volatility stood at about 38% (0.383) on 28 July 2026, with call IV near 39% and put IV near 38%. Against the framework's reference lines — up to roughly 50–55 acceptable, 60–70 elevated — a level near 38% is not elevated.

These are stated as facts, not as suggestions. The framework's own consequence follows from them plainly: qualifying long-dated options do exist and volatility is not prohibitive, so the name would not be routed to the watchlist on instrument grounds. What keeps it off the book under this system is upstream — the absence of a live dislocation to express, given a price at all-time highs.